As of 4:00pm ET
| +1.10 / +2.57%|
The 7 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 54.00, with a high estimate of 69.00 and a low estimate of 40.00. The median estimate represents a +23.12% increase from the last price of 43.86.
The current consensus among 7 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.